Hansoh Pharmaceutical Group Company Forecast, price target & analysts
Hansoh Pharmaceutical Group Company Target price 2024 - Analyst rating & recommendation
Hansoh Pharmaceutical Group Company Classifications & Recommendation:
Hansoh Pharmaceutical Group Company Price Target
| Target Price | HKD23.08 |
| Price | HKD17.08 |
| Potential |
35.12%
register free of charge
|
| Number of Estimates | 22 |
|
22 Analysts have issued a price target Hansoh Pharmaceutical Group Company 2025 .
The average Hansoh Pharmaceutical Group Company target price is HKD23.08.
This is
35.12%
register free of charge
HKD29.77
74.29%
register free of charge
HKD17.76
3.99%
register free of charge
|
|
| A rating was issued by 22 analysts: 20 Analysts recommend Hansoh Pharmaceutical Group Company to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Hansoh Pharmaceutical Group Company stock has an average upside potential 2025 of
35.12%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion HKD | 11.16 | 13.08 |
| 2.33% | 17.18% | |
| EBITDA Margin | 30.46% | 37.93% |
| 5.02% | 24.54% | |
| Net Margin | 32.42% | 34.63% |
| 16.89% | 6.81% |
22 Analysts have issued a sales forecast Hansoh Pharmaceutical Group Company 2024 . The average Hansoh Pharmaceutical Group Company sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Hansoh Pharmaceutical Group Company EBITDA forecast 2024. The average Hansoh Pharmaceutical Group Company EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Hansoh Pharmaceutical Group Company Analysts have issued a net profit forecast 2024. The average Hansoh Pharmaceutical Group Company net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share HKD | 0.61 | 0.76 |
| 19.61% | 24.59% | |
| P/E | 22.37 | |
| EV/Sales | 5.83 |
11 Analysts have issued a Hansoh Pharmaceutical Group Company forecast for earnings per share. The average Hansoh Pharmaceutical Group Company <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Hansoh Pharmaceutical Group Company stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Hansoh Pharmaceutical Group Company...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
